Administration on Intellectual and Developmental Disabilities, President's Committee for People With Intellectual Disabilities, 13853-13854 [2015-06085]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 51 / Tuesday, March 17, 2015 / Notices
999 E Street NW., Washington,
DC (Ninth Floor)
STATUS: This Meeting Will Be Open To
The Public.
ITEMS TO BE DISCUSSED: Correction and
Approval of Minutes for March 10, 2015
Draft Advisory Opinion 2014–20:
Make Your Laws PAC, Inc.
Rulemaking Petition REG 2014–09:
Federal Contractors, Draft Notice of
Availability
Rulemaking Petition REG 2015–01:
Administrative Fines and Forms, Draft
Notice of Availability
Management and Administrative
Matters
Individuals who plan to attend and
require special assistance, such as sign
language interpretation or other
reasonable accommodations, should
contact Shawn Woodhead Werth,
Secretary and Clerk, at (202) 694–1040,
at least 72 hours prior to the meeting
date.
PERSON TO CONTACT FOR INFORMATION:
Judith Ingram, Press Officer, Telephone:
(202) 694–1220.
PLACE:
Shawn Woodhead Werth,
Secretary and Clerk of the Commission.
[FR Doc. 2015–06147 Filed 3–13–15; 11:15 am]
BILLING CODE 6715–01–P
FEDERAL RESERVE SYSTEM
mstockstill on DSK4VPTVN1PROD with NOTICES
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S. C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S. C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the offices of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than March
31, 2015.
A. Federal Reserve Bank of Chicago
(Colette A. Fried, Assistant Vice
President) 230 South LaSalle Street,
Chicago, Illinois 60690–1414:
1. The Bradford Powers Leipold 2014
Trust, with Johnson Bank as trustee,
both of Racine, Wisconsin; to join the
existing Johnson Family Control Group
through the retention of shares of
VerDate Sep<11>2014
18:09 Mar 16, 2015
Jkt 235001
Johnson Financial Group, Inc., Racine,
Wisconsin, and the indirect retention of
shares of Johnson Bank, Racine,
Wisconsin.
Board of Governors of the Federal Reserve
System, March 12, 2015.
Michael J. Lewandowski,
Assistant Secretary of the Board.
[FR Doc. 2015–06049 Filed 3–16–15; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Community Living
Administration on Intellectual and
Developmental Disabilities, President’s
Committee for People With Intellectual
Disabilities
Administration for Community
Living, HHS.
ACTION: Notice.
AGENCY:
The President’s Committee
for People with Intellectual Disabilities
(PCPID) will host a webinar/conference
call for its members to discuss the
preparation of the 2015 Report to the
President (RTP). The topic of the PCPID
2015 RTP will be on the roles of
technology in the lives of individuals
with intellectual and developmental
disabilities and their families.
All the PCPID meetings, in any
format, are open to the public. This
webinar/conference call will be
conducted in a discussion format.
The public can register to attend this
webinar/conference call at https://aoaevents.webex.com/aoa-events/onstage/g.
php?MTID=e88689392224a29b0b
0110cff660d3e26.
DATES: Webinar: Tuesday, April 7, 2015
from 1:30 p.m. to approximately 3:30
p.m.
Registration for Webinar: March 16,
2015 through April 3, 2015.
ADDRESSES: Webinar Web page: https://
aoa-events.webex.com/aoa-events/
onstage/g.php?MTID=e886893
92224a29b0b0110cff660d3e26.
FOR FURTHER INFORMATION CONTACT: For
Reasonable Accomodations Contact: Dr.
MJ Karimi, PCPID Team Lead, One
Massachusetts Avenue NW., Room
4206, Washington, DC 20201. Email:
MJ.Karimie@acl.hhs.gov; telephone:
202–357–3588; fax: 202–205–8037.
SUPPLEMENTARY INFORMATION:
Background: The PCPID members
participated in a face-to-face meeting on
February 19–20, 2015 and streamlined
the process of preparing the 2015 RTP.
As the Phase I of the process, they
decided to research four focus areas
SUMMARY:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
13853
through the lens of technology. These
focus areas included:
1. Education;
2. Community Living;
3. Health and Wellness;
4. Economic Well-Being.
The members also agreed to
reconvene in April, through a webinar/
conference call, to report their findings
to the full Committee and discuss the
development of potential
recommendations for inclusion to the
PCPID 2015 RTP.
The general purpose of the PCPID
webinar/conference call is, thus, to
present a forum for the members to
complete Phase I and discuss the next
phase of preparing the PCPID 2015 RTP.
Webinar and Registration: The
webinar is scheduled for April 7, 2015,
1:30 p.m. to 3:30 p.m. (EST) and may
end early if discussions are finished.
Registration for the webinar is required
and is open from March 16, 2015 to
April 3, 2015.
Instructions to Register in the
Webinar/Conference Call on Tuesday
April 7, 2015:
1. WebEx Link: https://aoa-events.
webex.com/aoa-events/onstage/g.php
?MTID=e88689392224a29b0b0110cff
660d3e26.
2. Click on the ‘‘Register’’ button on
the page.
3. Enter the required information and
click ‘‘Submit.’’
Instructions to Participate in the
Webinar/Conference Call on Tuesday
April 7, 2015:
4. WebEx Link: https://aoa-events.
webex.com/aoa-events/onstage/g.php
?MTID=e88689392224a29b0b0110cff
660d3e26.
5. Click on the ‘‘join’’ button on the
page.
6. Enter your name and email address.
7. Follow additional instructions as
provided by WebEx. If a password is
needed for the WebEx link, please enter
123456.
Call-in number: (888) 469–0957; Pass
Code: 8955387 (please put your phone
on mute during the meeting).
Background information on PCPID:
The PCPID acts in an advisory capacity
to the President and the Secretary of
Health and Human Services, through
the Administration on Intellectual and
Developmental Disabilities, on a broad
range of topics relating to programs,
services and supports for persons with
intellectual disabilities. The PCPID
Executive Order stipulates that the
Committee shall: (1) Provide such
advice concerning intellectual
disabilities as the President or the
Secretary of Health and Human Services
may request; and (2) provide advice to
the President concerning the following
E:\FR\FM\17MRN1.SGM
17MRN1
13854
Federal Register / Vol. 80, No. 51 / Tuesday, March 17, 2015 / Notices
for people with intellectual disabilities:
(A) Expansion of educational
opportunities; (B) promotion of
homeownership; (C) assurance of
workplace integration; (D) improvement
of transportation options; (E) expansion
of full access to community living; and
(F) increasing access to assistive and
universally designed technologies.
Dated: March 11, 2015.
Aaron Bishop,
Commissioner, Administration on Intellectual
and Developmental Disabilities.
Dated: March 11, 2015.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–05968 Filed 3–16–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–1206]
BILLING CODE 4154–01–P
Authorization of Emergency Use of an
In Vitro Diagnostic Device for
Detection of Ebola Zaire Virus;
Availability
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
[FR Doc. 2015–06085 Filed 3–16–15; 8:45 am]
ACTION:
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; NINDS Center Core (P30)
and Research Resource (R24) Review.
Date: April 17, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Plaza Hotel, 10 Thomas
Circle NW., Washington, DC 20005.
Contact Person: Natalia Strunnikova,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Division of Extramural
Research, NINDS/NIH/DHHS/Neuroscience
Center, 6001 Executive Boulevard, Suite
3208, MSC 9529, Bethesda, MD 20892–9529,
301–402–0288, natalia.strunnikova@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
VerDate Sep<11>2014
18:09 Mar 16, 2015
Jkt 235001
Food and Drug Administration,
HHS.
Notice.
The Food and Drug
Administration (FDA) is announcing the
issuance of an Emergency Use
Authorization (EUA) (the Authorization)
for an in vitro diagnostic device for
detection of the Ebola Zaire virus in
response to the 2014 Ebola virus
outbreak in West Africa. FDA is issuing
this Authorization under the Federal
Food, Drug, and Cosmetic Act (the
FD&C Act), as requested by Roche
Molecular Systems, Inc. (Roche). The
Authorization contains, among other
things, conditions on the emergency use
of the authorized in vitro diagnostic
device. The Authorization follows the
September 22, 2006, determination by
then-Secretary of the Department of
Homeland Security (DHS), Michael
Chertoff, that the Ebola virus presents a
material threat against the U.S.
population sufficient to affect national
security. On the basis of such
determination, the Secretary of Health
and Human Services (HHS) declared on
August 5, 2014, that circumstances exist
justifying the authorization of
emergency use of in vitro diagnostics for
detection of Ebola virus subject to the
terms of any authorization issued under
the FD&C Act. The Authorization,
which includes an explanation of the
reasons for issuance, is reprinted in this
document.
DATES: The Authorization is effective as
of December 23, 2014.
ADDRESSES: Submit written requests for
single copies of the EUA to the Office
of Counterterrorism and Emerging
Threats, Food and Drug Administration,
10903 New Hampshire Ave., Bldg. 1,
rm. 4338, Silver Spring, MD 20993–
0002. Send one self-addressed adhesive
label to assist that office in processing
your request or include a fax number to
which the Authorization may be sent.
SUMMARY:
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
See the SUPPLEMENTARY INFORMATION
section for electronic access to the
Authorization.
FOR FURTHER INFORMATION CONTACT:
Luciana Borio, Assistant Commissioner
for Counterterrorism Policy, Office of
Counterterrorism and Emerging Threats,
and Acting Deputy Chief Scientist, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 1, rm. 4340,
Silver Spring, MD 20993–0002, 301–
796–8510 (this is not a toll free number).
SUPPLEMENTARY INFORMATION:
I. Background
Section 564 of the FD&C Act (21
U.S.C. 360bbb–3) as amended by the
Project BioShield Act of 2004 (Pub. L.
108–276) and the Pandemic and AllHazards Preparedness Reauthorization
Act of 2013 (Pub. L. 113–5) allows FDA
to strengthen the public health
protections against biological, chemical,
nuclear, and radiological agents. Among
other things, section 564 of the FD&C
Act allows FDA to authorize the use of
an unapproved medical product or an
unapproved use of an approved medical
product in certain situations. With this
EUA authority, FDA can help assure
that medical countermeasures may be
used in emergencies to diagnose, treat,
or prevent serious or life-threatening
diseases or conditions caused by
biological, chemical, nuclear, or
radiological agents when there are no
adequate, approved, and available
alternatives.
Section 564(b)(1) of the FD&C Act
provides that, before an EUA may be
issued, the Secretary of HHS must
declare that circumstances exist
justifying the authorization based on
one of the following grounds: (1) A
determination by the Secretary of
Homeland Security that there is a
domestic emergency, or a significant
potential for a domestic emergency,
involving a heightened risk of attack
with a biological, chemical, radiological,
or nuclear agent or agents; (2) a
determination by the Secretary of
Defense that there is a military
emergency, or a significant potential for
a military emergency, involving a
heightened risk to U.S. military forces of
attack with a biological, chemical,
radiological, or nuclear agent or agents;
(3) a determination by the Secretary of
HHS that there is a public health
emergency, or a significant potential for
a public health emergency, that affects,
or has a significant potential to affect,
national security or the health and
security of U.S. citizens living abroad,
and that involves a biological, chemical,
radiological, or nuclear agent or agents,
or a disease or condition that may be
E:\FR\FM\17MRN1.SGM
17MRN1
]]>Agencies
[Federal Register Volume 80, Number 51 (Tuesday, March 17, 2015)]
[Notices]
[Pages 13853-13854]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-06085]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Community Living
Administration on Intellectual and Developmental Disabilities,
President's Committee for People With Intellectual Disabilities
AGENCY: Administration for Community Living, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The President's Committee for People with Intellectual
Disabilities (PCPID) will host a webinar/conference call for its
members to discuss the preparation of the 2015 Report to the President
(RTP). The topic of the PCPID 2015 RTP will be on the roles of
technology in the lives of individuals with intellectual and
developmental disabilities and their families.
All the PCPID meetings, in any format, are open to the public. This
webinar/conference call will be conducted in a discussion format.
The public can register to attend this webinar/conference call at
https://aoa-events.webex.com/aoa-events/onstage/g.php?MTID=e88689392224a29b0b0110cff660d3e26.
DATES: Webinar: Tuesday, April 7, 2015 from 1:30 p.m. to approximately
3:30 p.m.
Registration for Webinar: March 16, 2015 through April 3, 2015.
ADDRESSES: Webinar Web page: https://aoa-events.webex.com/aoa-events/onstage/g.php?MTID=e88689392224a29b0b0110cff660d3e26.
FOR FURTHER INFORMATION CONTACT: For Reasonable Accomodations Contact:
Dr. MJ Karimi, PCPID Team Lead, One Massachusetts Avenue NW., Room
4206, Washington, DC 20201. Email: MJ.Karimie@acl.hhs.gov; telephone:
202-357-3588; fax: 202-205-8037.
SUPPLEMENTARY INFORMATION:
Background: The PCPID members participated in a face-to-face
meeting on February 19-20, 2015 and streamlined the process of
preparing the 2015 RTP. As the Phase I of the process, they decided to
research four focus areas through the lens of technology. These focus
areas included:
1. Education;
2. Community Living;
3. Health and Wellness;
4. Economic Well-Being.
The members also agreed to reconvene in April, through a webinar/
conference call, to report their findings to the full Committee and
discuss the development of potential recommendations for inclusion to
the PCPID 2015 RTP.
The general purpose of the PCPID webinar/conference call is, thus,
to present a forum for the members to complete Phase I and discuss the
next phase of preparing the PCPID 2015 RTP.
Webinar and Registration: The webinar is scheduled for April 7,
2015, 1:30 p.m. to 3:30 p.m. (EST) and may end early if discussions are
finished. Registration for the webinar is required and is open from
March 16, 2015 to April 3, 2015.
Instructions to Register in the Webinar/Conference Call on Tuesday
April 7, 2015:
1. WebEx Link: https://aoa-events.webex.com/aoa-events/onstage/g.php?MTID=e88689392224a29b0b0110cff660d3e26.
2. Click on the ``Register'' button on the page.
3. Enter the required information and click ``Submit.''
Instructions to Participate in the Webinar/Conference Call on
Tuesday April 7, 2015:
4. WebEx Link: https://aoa-events.webex.com/aoa-events/onstage/g.php?MTID=e88689392224a29b0b0110cff660d3e26.
5. Click on the ``join'' button on the page.
6. Enter your name and email address.
7. Follow additional instructions as provided by WebEx. If a
password is needed for the WebEx link, please enter 123456.
Call-in number: (888) 469-0957; Pass Code: 8955387 (please put your
phone on mute during the meeting).
Background information on PCPID: The PCPID acts in an advisory
capacity to the President and the Secretary of Health and Human
Services, through the Administration on Intellectual and Developmental
Disabilities, on a broad range of topics relating to programs, services
and supports for persons with intellectual disabilities. The PCPID
Executive Order stipulates that the Committee shall: (1) Provide such
advice concerning intellectual disabilities as the President or the
Secretary of Health and Human Services may request; and (2) provide
advice to the President concerning the following
[[Page 13854]]
for people with intellectual disabilities: (A) Expansion of educational
opportunities; (B) promotion of homeownership; (C) assurance of
workplace integration; (D) improvement of transportation options; (E)
expansion of full access to community living; and (F) increasing access
to assistive and universally designed technologies.
Dated: March 11, 2015.
Aaron Bishop,
Commissioner, Administration on Intellectual and Developmental
Disabilities.
[FR Doc. 2015-06085 Filed 3-16-15; 8:45 am]
BILLING CODE 4154-01-P
